Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Munter K ^a   Hergenroder S ^a   Kirchengast, M ^a  

^a Knoll AG   (Germany)

Author keywords

Endothelin; Hydralazine; Hypercholesterolemia; Hypertension; Renal function

Indexed keywords

ANTIHYPERTENSIVE AGENT; DARUSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; HYDRALAZINE; PHENYLPROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TEST; MALE; MORTALITY; PATHOPHYSIOLOGY; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HYDRALAZINE; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TESTS; MALE; PHENYLPROPIONATES; PROTEINURIA; PYRIMIDINES; RATS; RATS, INBRED SHR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SURVIVAL;

EID: 0031638060     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00069     Document Type: Article

References (19)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993;21:747-51.
3. Lüscher TF, Seo B, Bühler FR. Potential role of endothelin in hypertension. Hypertension 1993;21:752-7.
4. A-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol 1997; 121:935-40.
5. Bird EJ, Moreland SD, Waldron TL, et al. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 1995;25:1191-5.
6. Richard V, Hogie M, Clozel M, et al. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rat. Circulation 1995;91:771-5.
7. A-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett 1996;6:90-2.
8. A-receptor blockade on blood pressure and endothelial function in chronic nitric oxide deficiency. Hypertension 1996; 28:695.
9. Moreau P, Takase H, Küng CF, et al. Blood pressure and vascular effects of endothelin receptor blockade in chronic nitric oxide-deficient hypertension. Hypertension 1997;29:763-9.
10. Ikeda K, Nara Y, Tagami M, et al. Myocardial infarction model by NO synthesis inhibition in hypercholesterolemic SHRSP. J Hypertens 1996;14:S123.
11. G-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 1990;99: 408-12.
12. Brockway BP, Mills PA, Azar SH. A new method of continuous measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens Theory Pract 1991;A13:885-95.
13. Gries J, Kretzschmar R, Neumann WB. Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J Cardiovasc Pharmacol 1989;13(suppl 5):S79-82.
14. Münter K, Hergenröder S, Jochims K, et al. Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopathic changes in the stroke-prone rat. J Am Soc Nephrol 1996;7:1-7.
15. Münter K, Gries J, Hergenröder S, et al. Nephroprotection increases survival in stroke-prone spontaneously hypertensive rats. Pharm Pharmacol Lett 1995;5:146-9.
16. A endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation 1997;95:240-4.
17. A receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade? J Cardiovasc Pharmacol 1995;26(suppl 3):S462-5.
18. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol 1995;6:1476-81.
19. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992;13:103-8.